NVO logo

Novo Nordisk A/S (NVO) Shareholders equity

annual shareholders equity:

$19.92B+$4.13B(+26.18%)
December 31, 2024

Summary

  • As of today (August 23, 2025), NVO annual stockholders equity is $19.92 billion, with the most recent change of +$4.13 billion (+26.18%) on December 31, 2024.
  • During the last 3 years, NVO annual shareholders equity has risen by +$9.11 billion (+84.19%).
  • NVO annual shareholders equity is now at all-time high.

Performance

NVO Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly shareholders equity:

$26.44B+$6.38B(+31.83%)
June 1, 2025

Summary

  • As of today (August 23, 2025), NVO quarterly stockholders equity is $26.44 billion, with the most recent change of +$6.38 billion (+31.83%) on June 1, 2025.
  • Over the past year, NVO quarterly shareholders equity has increased by +$10.27 billion (+63.52%).
  • NVO quarterly shareholders equity is now at all-time high.

Performance

NVO quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

NVO Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.2%+63.5%
3 y3 years+84.2%+152.6%
5 y5 years+130.3%+192.2%

NVO Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+84.2%at high+161.7%
5 y5-yearat high+130.3%at high+192.2%
alltimeall timeat high>+9999.0%at high+6607.5%

NVO Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$26.44B(+31.8%)
Mar 2025
-
$20.06B(+0.7%)
Dec 2024
$19.92B(+26.2%)
$19.92B(+10.4%)
Sep 2024
-
$18.04B(+11.6%)
Jun 2024
-
$16.17B(+12.9%)
Mar 2024
-
$14.32B(-9.3%)
Dec 2023
$15.79B(+31.8%)
$15.79B(+19.6%)
Sep 2023
-
$13.20B(-0.4%)
Jun 2023
-
$13.26B(+13.8%)
Mar 2023
-
$11.65B(-2.8%)
Dec 2022
$11.98B(+10.8%)
$11.98B(+18.6%)
Sep 2022
-
$10.10B(-3.5%)
Jun 2022
-
$10.47B(+5.1%)
Mar 2022
-
$9.95B(-8.0%)
Dec 2021
$10.82B(+3.9%)
$10.82B(+5.0%)
Sep 2021
-
$10.30B(-1.4%)
Jun 2021
-
$10.46B(+13.1%)
Mar 2021
-
$9.24B(-11.2%)
Dec 2020
$10.41B(+20.3%)
$10.41B(+10.9%)
Sep 2020
-
$9.38B(+3.7%)
Jun 2020
-
$9.05B(+13.1%)
Mar 2020
-
$8.00B(-7.5%)
Dec 2019
$8.65B(+8.9%)
$8.65B(+11.9%)
Sep 2019
-
$7.73B(-4.5%)
Jun 2019
-
$8.10B(+13.8%)
Mar 2019
-
$7.12B(-10.4%)
Dec 2018
$7.94B(-1.2%)
$7.94B(+7.3%)
Sep 2018
-
$7.40B(-3.8%)
Jun 2018
-
$7.69B(+5.4%)
Mar 2018
-
$7.30B(-9.2%)
Dec 2017
$8.03B(+25.1%)
$8.03B(+7.7%)
Sep 2017
-
$7.46B(+0.4%)
Jun 2017
-
$7.43B(+28.2%)
Mar 2017
-
$5.80B(-9.7%)
Dec 2016
$6.42B(-6.1%)
$6.42B(+3.0%)
Sep 2016
-
$6.24B(-1.9%)
Jun 2016
-
$6.36B(+11.5%)
Mar 2016
-
$5.70B(-16.6%)
Dec 2015
$6.84B(+4.4%)
$6.84B(+6.0%)
Sep 2015
-
$6.45B(+10.4%)
Jun 2015
-
$5.84B(+26.6%)
Mar 2015
-
$4.62B(-29.5%)
Dec 2014
$6.55B(-16.7%)
$6.55B(+1.6%)
Sep 2014
-
$6.44B(-4.3%)
Jun 2014
-
$6.73B(+8.6%)
Mar 2014
-
$6.20B(-21.2%)
Dec 2013
$7.86B(+9.5%)
$7.86B(+10.7%)
Sep 2013
-
$7.10B(+15.2%)
Jun 2013
-
$6.16B(+5.8%)
Mar 2013
-
$5.82B(-18.9%)
Dec 2012
$7.18B(+9.8%)
$7.18B(+16.7%)
Sep 2012
-
$6.15B(+15.1%)
Jun 2012
-
$5.35B(-7.7%)
Mar 2012
-
$5.79B(-11.4%)
Dec 2011
$6.54B(-1.7%)
$6.54B(+2.4%)
Sep 2011
-
$6.39B(-11.1%)
Jun 2011
-
$7.19B(+8.6%)
Mar 2011
-
$6.62B(-0.6%)
Dec 2010
$6.65B
$6.65B(+6.0%)
Sep 2010
-
$6.28B(+13.5%)
DateAnnualQuarterly
Jun 2010
-
$5.53B(-7.6%)
Mar 2010
-
$5.98B(-13.2%)
Dec 2009
$6.89B(+11.9%)
$6.89B(+0.6%)
Sep 2009
-
$6.85B(+6.7%)
Jun 2009
-
$6.42B(+14.9%)
Mar 2009
-
$5.59B(-9.3%)
Dec 2008
$6.16B(-2.4%)
$6.16B(+1.7%)
Sep 2008
-
$6.06B(-13.2%)
Jun 2008
-
$6.98B(+5.1%)
Mar 2008
-
$6.64B(+5.2%)
Dec 2007
$6.31B(+18.4%)
$6.31B(-0.3%)
Sep 2007
-
$6.33B(+4.1%)
Jun 2007
-
$6.08B(+14.6%)
Mar 2007
-
$5.30B(-0.5%)
Dec 2006
$5.33B(+21.9%)
$5.33B(+10.9%)
Sep 2006
-
$4.81B(-3.0%)
Jun 2006
-
$4.96B(+13.0%)
Mar 2006
-
$4.39B(+0.3%)
Dec 2005
$4.37B(-9.8%)
$4.37B(+1.7%)
Sep 2005
-
$4.30B(+3.2%)
Jun 2005
-
$4.16B(-7.3%)
Mar 2005
-
$4.49B(-7.3%)
Dec 2004
$4.84B(+13.3%)
$4.84B(+13.1%)
Sep 2004
-
$4.28B(+4.9%)
Jun 2004
-
$4.08B(+2.8%)
Mar 2004
-
$3.97B(-7.1%)
Dec 2003
$4.27B(+31.9%)
$4.27B(+13.3%)
Sep 2003
-
$3.77B(+5.3%)
Jun 2003
-
$3.58B(+9.9%)
Mar 2003
-
$3.26B(+0.5%)
Dec 2002
$3.24B(+34.3%)
$3.24B(+10.7%)
Sep 2002
-
$2.93B(+4.1%)
Jun 2002
-
$2.81B(+21.1%)
Mar 2002
-
$2.32B(-3.7%)
Dec 2001
$2.41B(+21.8%)
$2.41B(+5.4%)
Sep 2001
-
$2.29B(+13.4%)
Jun 2001
-
$2.02B(+1.5%)
Mar 2001
-
$1.99B(+0.5%)
Dec 2000
$1.98B(-20.7%)
$1.98B(-22.6%)
Dec 1999
$2.50B(-11.6%)
-
Jun 1999
-
$2.56B(-9.1%)
Dec 1998
$2.82B(+7.7%)
$2.82B(+5.9%)
Dec 1997
$2.62B(-2.6%)
$2.66B(-1.4%)
Dec 1996
$2.69B(+4.2%)
$2.69B(+3.8%)
Dec 1995
$2.58B(+20.6%)
$2.60B(+20.2%)
Dec 1994
$2.14B(+23.0%)
$2.16B(+22.3%)
Dec 1993
$1.74B(+4.2%)
$1.77B(+4.6%)
Dec 1992
$1.67B(+5.0%)
$1.69B(+5.0%)
Dec 1991
$1.59B(+31.6%)
$1.61B(+32.2%)
Dec 1990
$1.21B(+28.3%)
$1.22B(+28.5%)
Dec 1989
$942.11M(+17.6%)
$946.19M(+17.8%)
Dec 1988
$801.41M(-4.7%)
$803.00M(-5.1%)
Dec 1987
$841.04M(+25.9%)
$846.44M(+52.7%)
Dec 1986
$668.12M(+21.8%)
$554.32M(+1.1%)
Dec 1985
$548.43M(+39.2%)
$548.05M(+39.0%)
Dec 1984
$393.92M(+2.2%)
$394.23M
Dec 1983
$385.61M(+45.3%)
-
Dec 1982
$265.39M(+8.5%)
-
Dec 1981
$244.66M(+53.4%)
-
Dec 1980
$159.51M
-

FAQ

  • What is Novo Nordisk A/S annual stockholders equity?
  • What is the all time high annual shareholders equity for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual shareholders equity year-on-year change?
  • What is Novo Nordisk A/S quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly shareholders equity year-on-year change?

What is Novo Nordisk A/S annual stockholders equity?

The current annual shareholders equity of NVO is $19.92B

What is the all time high annual shareholders equity for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual stockholders equity is $19.92B

What is Novo Nordisk A/S annual shareholders equity year-on-year change?

Over the past year, NVO annual stockholders equity has changed by +$4.13B (+26.18%)

What is Novo Nordisk A/S quarterly stockholders equity?

The current quarterly shareholders equity of NVO is $26.44B

What is the all time high quarterly shareholders equity for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly stockholders equity is $26.44B

What is Novo Nordisk A/S quarterly shareholders equity year-on-year change?

Over the past year, NVO quarterly stockholders equity has changed by +$10.27B (+63.52%)
On this page